Capnia, Inc Stock Company Profile
Information
1235 Radio Road
Redwood City CA 94065
650-213-8444
Description
Capnia, Inc. develops and commercializes neonatology devices, diagnostics, and therapeutics platform based on its proprietary technology for precision metering of gas flow primarily in the United States. The company offers CoSense, an end-tidal carbon monoxide monitor, for the diagnosis of excessive hemolysis in neonates with jaundice, a condition that causes long-term developmental disability due to the degradation of red blood cells. It also develops Serenz, a therapeutic product candidate that has completed Phase II clinical trials for the treatment of symptoms related to allergic rhinitis. In addition, the company provides NeoPip T-piece resuscitator and related consumables, which delivers consistent pre-set inspiratory pressure and positive end-expiratory pressures; temperature probes; scales; surgical tables; and patient surfaces for inpatient and ambulatory neonatal markets. Capnia, Inc. was founded in 1999 and is headquartered in Redwood City, California.